Involvement of the lymphocytic muscarinic acetylcholine receptor in methylmercury-induced c-Fos expression and apoptosis in human leukemic T cells

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 71, Issue 16, 2008, Pages 1109-1123

  Suriyo, Tawit ^a   Thiantanawat, Apinya ^b   Chaiyaroj, Sansanee C ^a,b   Parkpian, Preeda ^c   Satayavivad, Jutamaad ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Chulabhorn Research Institute   (Thailand)

^c ASIAN INSTITUTE OF TECHNOLOGY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; INTERLEUKIN 2; METHYLMERCURY; MITOGEN ACTIVATED PROTEIN KINASE P38; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PROTEIN C FOS; RECEPTOR SUBTYPE; 4 DIPHENYLACETOXY 1,1 DIMETHYLPIPERIDINIUM; 4-DIPHENYLACETOXY-1,1-DIMETHYLPIPERIDINIUM; METHYLMERCURIC CHLORIDE; METHYLMERCURY DERIVATIVE; PIPERIDINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; DRUG INTERACTION; LEUKEMIA CELL LINE; METABOLISM; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; DRUG INTERACTIONS; GENES, FOS; HUMANS; JURKAT CELLS; METHYLMERCURY COMPOUNDS; MUSCARINIC ANTAGONISTS; PIPERIDINES; RECEPTORS, MUSCARINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 46749118792     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390802114725     Document Type: Article

References (41)

1. Atchison, W. D. 2005. Is chemical neurotransmission altered specifically during methylmercury-induced cerebellar dysfunction? Trends Pharmacol. Sci. 26:549-557.
2. Bany, U., Ryzewski, J., and Maslinski, W. 1999. Relative amounts of mRNA encoding four subtypes of muscarinic receptors (M2-M5) in human peripheral blood mononuclear cells. J. Neuroimmunol. 97:191-195.
3. Basu, N., Kwan, M., and Chan, H. M. 2006. Mercury but not organochlorines inhibits muscarinic cholinergic receptor binding in the cerebrum of ringed seals (Phoca hispida). J Toxicol. Environ. Health A 69:1133-1143.
4. Basu, N., Stamler, C. J., Loua, K. M., and Chan, H. M. 2005. An interspecies comparison of mercury inhibition on muscarinic acetylcholine receptor binding in the cerebral cortex and cerebellum. Toxicol. Appl. Pharmacol. 205:71-76.
5. Castoldi, A. F., Candura, S. M., Costa, P., Manzo, L., and Costa, L. G. 1996. Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. Neurotoxicology 17:735-741.
6. Cheng, J. P., Wang, W. H., Jia, J. P., Zheng, M., Shi, W., and Lin, X. Y. 2006. Expression of c-Fos in rat brain as a prelude marker of central nervous system injury in response to methylmercury-stimulation. Biomed. Environ. Sci. 19:67-72.
7. Chetty, C. S., Rajanna, S., Hall, E., Yallapragada, P. R., and Rajanna, B. 1996. In vitro and in vivo effects of lead, methyl mercury and mercury on inositol 1,4,5-trisphosphate and 1,3,4,5-tetrakisphosphate receptor bindings in rat brain. Toxicol. Lett. 87:11-17.
8. Coccini, T., Randine, G., Candura, S. M., Nappi, R. E., Prockop, L. D., and Manzo, L. 2000. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: Physiologic implications and new opportunities in biologic monitoring. Environ. Health Perspect. 108:29-33.
9. Coccini, T., Randine, G., Castoldi, A. F., Acerbi, D., and Manzo, L. 2007. Methylmercury interaction with lymphocyte cholinergic muscarinic receptors in developing rats. Environ. Res. 103:229-237.
10. Cohen, D. R., and Curran, T. 1989. The structure and function of the fos proto-oncogene. Crit. Rev. Oncogen. 1:65-88.
11. Colombo, M., Hamelin, C., Kouassi, E., Fournier, M., and Bernier, J. 2004. Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells. Clin. Immunol. 111:311-322.
12. Costa, L. G., Kaylor, G., and Murphy, S. D. 1990. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents. Int. J. Immunopharmacol. 12:67-75.
13. Distel, R. J., and Spiegelman, B. M. 1990. Protooncogene c-Fos as a transcription factor. Adv. Cancer Res. 55:37-55.
14. Dourson, M. L., Wullenweber, A. E., and Poirier, K. A. 2001. Uncertainties in the reference dose for methylmercury. Neurotoxicology 22:677-689.
15. Eldefrawi, M. E., Mansour, N. A., and Eldefrawi, A. T. 1977. Interactions of acetylcholine receptors with organic mercury compounds. Adv. Exp. Med. Biol. 84:449-463.
16. Fujii, T., and Kawashima, K. 2000. Calcium signaling and c-Fos gene expression via M3 muscarinic acetylcholine receptors in human T- and B-cells. Jpn. J. Pharmacol. 84:124-132.
17. + pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J. Neurosci. Res. 66:135-145.
18. Gillis, S., Scheid, M., and Watson, J. 1980. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of interleukin-2 producing T cell lymphomas. J. Immunol. 125:2570-2578.
19. Guo, L., Bi, X., Li, Z., and Zhang, C. 2002. Effect of methylmercuric chloride on apoptosis and c-Fos expression of brain glial cells. Wei Sheng Yan Jiu 31:7-9.
20. Ilback, N., Wesslen, L., Fohlman, J., and Friman, G. 1996. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis). Toxicol. Lett. 89:19-28.
21. Kawashima, K., and Fujii, T. 2004. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 9:2063-2085.
22. Kim, S. H., and Sharma, R. P. 2004. Mercury-induced apoptosis and necrosis in murine macrophages: Role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicol. Appl. Pharmacol. 196:47-57.
23. 2+ dysregulation and neuronal death in rat cerebellar granule cells through an M3 muscarinic receptor-linked pathway. Toxicol. Sci. 80:60-68.
24. Limke, T. L., Otero-Montanez, J. K., and Atchison, W. D. 2003. Evidence for interactions between intracellular calcium stores during methylmercury-induced intracellular calcium dysregulation in rat cerebellar granule neurons. J. Pharmacol. Exp. Ther. 304:949-958.
25. Matsuoka, M., Wispriyono, B., and Igisu, H. 1997. Induction of c-Fos gene by mercury chloride in LLC-PK1 cells. Chem. Biol. Interact. 108:95-106.
26. Moszczynski, P. 1997. Mercury compounds and the immune system: A review. Int. J. Occup. Med. Environ. Health 10:247-258.
27. National Research Council (U.S.) Board on Environmental Studies and Toxicology. 2000. Toxicological effects of methylmercury. Washington DC: National Academy Press.
28. Ortega, H. G., Lopez, M., Salvaggio, J. E., Reimers, R., Hsiao-Lin, C., Bollinger, J. E., and George, W. 1997. Lymphocyte proliferative response and tissue distribution of methylmercury sulfide and chloride in exposed rats. J. Toxicol. Environ. Health 50:605-616.
29. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
30. Pheng, S., Chakrabarti, S., and Lamontagne, L. 2000. Dose-dependent apoptosis induced by low concentrations of methylmercury in murine splenic Fas+ T cell subsets. Toxicology 149:115-128.
31. Ratcliffe, H. E., Swanson, G. M., and Fischer, L. J. 1996. Human exposure to mercury: A critical assessment of the evidence of adverse health effects. J. Toxicol. Environ. Health 49:221-270.
32. Ricci, A., Amenta, F., Bronzetti, E., Mannino, F., Mariotta, S., and Tayebati, S. K. 2002. Expression of peripheral blood lymphocyte muscarinic cholinergic receptor subtypes in airway hyperresponsiveness. J. Neuroimmunol. 129:178-185.
33. Risher, J. F., Murray, H. E., and Prince, G. R. 2002. Organic mercury compounds: Human exposure and its relevance to public health. Toxicol. Ind. Health 18:109-160.
34. Shaulian, E., and Karin, M. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136.
35. Shenker, B. J., Pankoski, L., Zekavat, A., and Shapiro, I. M. 2002. Mercury-induced apoptosis in human lymphocytes: Caspase activation is linked to redox status. Antioxid. Redox. Signal 4:379-389.
36. Sweet, L. I., and Zelikoff, J. T. 2001. Toxicology and immunotoxicology of mercury: A comparative review in fish and humans. J. Toxicol. Environ. Health B 4:161-205.
37. Teng, C. S. 2000. Protooncogenes as mediators of apoptosis. Int. Rev. Cytol. 197:137-202.
38. Thompson, S. A., Roellich, K. L., Grossmann, A., Gilbert, S. G., and Kavanagh, T. J. 1998. Alterations in immune parameters associated with low level methylmercury exposure in mice. Immunopharmacol. Immunotoxicol. 20:299-314.
39. Verity, M. A., Sarafian, T., Pacifici, E. H., and Sevanian, A. 1994. Phospholipase A2 stimulation by methyl mercury in neuron culture. J. Neurochem. 62:705-714.
40. Von Burg, R., Northington, F. K., and Shamoo, A. 1980. Methylmercury inhibition of rat brain muscarinic receptors. Toxicol. Appl. Pharmacol. 53:285-292.
41. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.